Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice

Molecular and Cellular Neuroscience

Volumn 70, Issue , 2016, Pages 30-41

  Neve, Anuja ^a   Trüb, Judith ^a   Saxena, Smita ^a   Schümperli, Daniel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Diaphragm; Motoneuron; Neuromuscular junction; Perisynaptic Schwann cell; Proteomics; Spinal muscular atrophy

Indexed keywords

APOPTOSIS INDUCING FACTOR 1; FLAVOPROTEIN; FOUR AND A HALF LIM DOMAIN PROTEIN 1; LIM PROTEIN; PROTEIN S 100; UNCLASSIFIED DRUG; APOPTOSIS INDUCING FACTOR; FHL1 PROTEIN, HUMAN; MUSCLE PROTEIN; PDCD8 PROTEIN, MOUSE; SIGNAL PEPTIDE; SURVIVAL MOTOR NEURON PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGENERATION; DIAPHRAGM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MITOCHONDRION; MOTONEURON; MOTOR UNIT; MOUSE; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SCHWANN CELL; SPINAL CORD; SPINAL MUSCULAR ATROPHY; SYNAPSE VESICLE; UPREGULATION; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; GENETICS; INNERVATION; METABOLISM; NEUROMUSCULAR JUNCTION; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS INDUCING FACTOR; DIAPHRAGM; DISEASE MODELS, ANIMAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; MICE; MOTOR NEURONS; MUSCLE PROTEINS; MUSCULAR ATROPHY, SPINAL; NEUROMUSCULAR JUNCTION; PROTEOMICS; SCHWANN CELLS; SURVIVAL OF MOTOR NEURON 1 PROTEIN; SYNAPTIC VESICLES;

EID: 84949294054     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.11.007     Document Type: Article

References (78)

1. Acsadi G., Lee I., Li X., Khaidakov M., Pecinova A., Parker G.C., Hüttemann M. Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. J. Neurosci. Res. 2009, 87:2748-2756.
2. Aghamaleky Sarvestany A., Hunter G., Tavendale A., Lamont D.J., Llavero Hurtado M., Graham L.C., Wishart T.M., Gillingwater T.H. Label-free quantitative proteomic profiling identifies disruption of ubiquitin homeostasis as a key driver of Schwann cell defects in spinal muscular atrophy. J. Proteome Res. 2014, 13:4546-4557.
3. Alías L., Bernal S., Fuentes-Prior P., Barceló M.J., Also E., Martínez-Hernández R., Rodríguez-Alvarez F.J., Martín Y., Aller E., Grau E. Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum. Genet. 2009, 125:29-39.
4. Anagnostou E., Miller S.P., Guiot M.-C., Karpati G., Simard L., Dilenge M.-E., Shevell M.I. Type I spinal muscular atrophy can mimic sensory-motor axonal neuropathy. J. Child Neurol. 2005, 20:147-150.
5. Arbour D., Tremblay E., Martineau É., Julien J.-P., Robitaille R. Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model. J. Neurosci. 2015, 35:688-706.
6. Auld D., Robitaille R. Perisynaptic Schwann cells at the neuromuscular junction: nerve-and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation. Neuroscientist 2003, 9:144.
7. Baker M.J., Tatsuta T., Langer T. Quality control of mitochondrial proteostasis. Cold Spring Harb. Perspect. Biol. 2011, 3:a007559.
8. Barbour J.A., Turner N. Mitochondrial stress signaling promotes cellular adaptations. Int. J. Cell Biol. 2014, 2014.
9. Ben-Ari Y., Gaiarsa J.-L., Tyzio R., Khazipov R. GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol. Rev. 2007, 87:1215-1284.
10. Buchthal F., Olsen P. Electromyography and muscle biopsy in infantile spinal muscular atrophy. Brain J. Neurol. 1970, 93:15.
11. Burghes A. When is a deletion not a deletion? When it is converted. Am. J. Hum. Genet. 1997, 61:9.
12. Cartegni L., Krainer A.R. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 2002, 30:377-384.
13. Cartegni L., Hastings M.L., Calarco J.A., de Stanchina E., Krainer A.R. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am. J. Hum. Genet. 2006, 78:63-77.
14. Chang Q., Martin L.J. Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: a quantitative confocal analysis. Am. J. Pathol. 2009, 174:574-585.
15. Cope T.C. Motor Neurobiology of the Spinal Cord 2001, CRC Press.
16. Cowling B.S., McGrath M.J., Nguyen M.-A., Cottle D.L., Kee A.J., Brown S., Schessl J., Zou Y., Joya J., Bönnemann C.G., Hardeman E.C., Mitchell C.A. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. J. Cell Biol. 2008, 183:1033-1048.
17. Crawford T.O. Spinal Muscular Atrophies. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach 2003, 145-166. Butterworth Heinemann, Philadelphia, PA.
18. Dachs E., Hereu M., Piedrafita L., Casanovas A., Calderó J., Esquerda J.E. Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy. J. Neuropathol. Exp. Neurol. 2011, 70:444-461. (410.1097/NEN.1090b1013e31821cbd31828b).
19. D'Arcy C.E., Feeney S.J., McLean C.A., Gehrig S.M., Lynch G.S., Smith J.E., Cowling B.S., Mitchell C.A., McGrath M.J. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy. Hum. Mol. Genet. 2014, 23:618-636.
20. Diodato D., Tasca G., Verrigni D., D'Amico A., Rizza T., Tozzi G., Martinelli D., Verardo M., Invernizzi F., Nasca A., Bellacchio E., Ghezzi D., Piemonte F., Dionisi-Vici C., Carrozzo R., Bertini E. A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease. Eur. J. Hum. Genet. 2015, (Epub ahead of print). 10.1038/ejhg.2015.141.
21. Domenighetti A.A., Chu P.-H., Wu T., Sheikh F., Gokhin D.S., Guo L.T., Cui Z., Peter A.K., Christodoulou D.C., Parfenov M.G., Gorham J.M., Li D.Y., Banerjee I., Lai X., Witzmann F.A., Seidman C.E., Seidman J.G., Gomes A.V., Shelton G.D., Lieber R.L., Chen J. Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice. Hum. Mol. Genet. 2014, 23:209-225.
22. Emery A. The nosology of the spinal muscular atrophies. J. Med. Genet. 1971, 8:481.
23. Feng Z., Ko C.P. Neuronal glia interactions at the vertebrate neuromuscular junction. Curr. Opin. Pharmacol. 2007, 7:316-324.
24. Feng Z., Ko C.-P. Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-β1. J. Neurosci. 2008, 28:9599-9609.
25. Frank S., Gaume B., Bergmann-Leitner E.S., Leitner W.W., Robert E.G., Catez F., Smith C.L., Youle R.J. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 2001, 1:515-525.
26. Hamilton G., Gillingwater T.H. Spinal muscular atrophy: going beyond the motor neuron. Trends Mol. Med. 2013, 19:40-50.
27. Hunter G., Sarvestany A.A., Roche S.L., Symes R.C., Gillingwater T.H. SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 2013, (ddt612).
28. Imlach W.L., Beck E.S., Choi B.J., Lotti F., Pellizzoni L., McCabe B.D. SMN is required for sensory-motor circuit function in Drosophila. Cell 2012, 151:427-439.
29. Jablonka S., Karle K., Sandner B., Andreassi C., von Au K., Sendtner M. Distinct and overlapping alterations in motor and sensory neurons in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 2006, 15:511-518.
30. Jiang M., Schuster J.E., Fu R., Siddique T., Heckman C. Progressive changes in synaptic inputs to motoneurons in adult sacral spinal cord of a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2009, 29:15031-15038.
31. Joza N., Susin S.A., Daugas E., Stanford W.L., Cho S.K., Li C.Y., Sasaki T., Elia A.J., Cheng H.-Y.M., Ravagnan L. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001, 410:549-554.
32. Kariya S., Park G.H., Maeno-Hikichi Y., Leykekhman O., Lutz C., Arkovitz M.S., Landmesser L.T., Monani U.R. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 2008, 17:2552-2569.
33. Kashima T., Manley J.L. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet. 2003, 34:460-463.
34. Kong L., Wang X., Choe D.W., Polley M., Burnett B.G., Bosch-Marcé M., Griffin J.W., Rich M.M., Sumner C.J. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci. 2009, 29:842-851.
35. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
36. Lee Y.i., Mikesh M., Smith I., Rimer M., Thompson W. Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons. Dev. Biol. 2011, 356:432-444.
37. Lee J.-H., Cheon Y.-H., Woo R.-S., Song D.-Y., Moon C., Baik T.-K. Evidence of early involvement of apoptosis inducing factor-induced neuronal death in Alzheimer brain. Anat. Cell Biol. 2012, 45:26-37.
38. Lefebvre S., Bürglen L., Reboullet S., Clermont O., Burlet P., Viollet L., Benichou B., Cruaud C., Millasseau P., Zeviani M. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80:155-165.
39. Ling K.K., Lin M.-Y., Zingg B., Feng Z., Ko C.-P. Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PLoS One 2010, 5.
40. Ling K.K., Gibbs R.M., Feng Z., Ko C.-P. Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 2012, 21:185-195.
41. Lorson C.L., Androphy E.J. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet. 2000, 9:259-265.
42. Lorson C., Hahnen E., Androphy E., Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6307.
43. Loughna P.T., Mason P., Bayol S., Brownson C. The LIM-domain protein FHL1 (SLIM 1) exhibits functional regulation in skeletal muscle. Mol. Cell Biol. Res. Commun. 2000, 3:136-140.
44. Mattiazzi M., D'Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002, 277:29626-29633.
45. McGovern V.L., Gavrilina T.O., Beattie C.E., Burghes A.H.M. Embryonic motor axon development in the severe SMA mouse. Hum. Mol. Genet. 2008, 17:2900-2909.
46. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 1994, 36:747-751.
47. Mentis G.Z., Blivis D., Liu W., Drobac E., Crowder M.E., Kong L., Alvarez F.J., Sumner C.J., O'Donovan M.J. Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron 2011, 69:453-467.
48. Meyer K., Marquis J., Trüb J., Nlend Nlend R., Verp S., Ruepp M., Imboden H., Barde I., Trono D., Schümperli D. Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation. Hum. Mol. Genet. 2009, 18:546.
49. Michaud M., Arnoux T., Bielli S., Durand E., Rotrou Y., Jablonka S., Robert F., Giraudon-Paoli M., Riessland M., Mattei M.G., Andriambeloson E., Wirth B., Sendtner M., Gallego J., Pruss R.M., Bordet T. Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiol. Dis. 2010, 38:125-135.
50. Millino C., Fanin M., Vettori A., Laveder P., Mostacciuolo M.L., Angelini C., Lanfranchi G. Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy. BMC Med. 2009, 7:14.
51. Monani U.R., Lorson C.L., Parsons D.W., Prior T.W., Androphy E.J., Burghes A.H., McPherson J.D. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 1999, 8:1177-1183.
52. Monani U.R., Sendtner M., Coovert D.D., Parsons D.W., Andreassi C., Le T.T., Jablonka S., Schrank B., Rossol W., Prior T.W. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 2000, 9:333-339.
53. Murray L.M., Comley L.H., Thomson D., Parkinson N., Talbot K., Gillingwater T.H. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 2008, 17:949-962.
54. Murray L.M., Lee S., Bäumer D., Parson S.H., Talbot K., Gillingwater T.H. Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum. Mol. Genet. 2010, 19:420.
55. Murray L.M., Talbot K., Gillingwater T.H. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol. Appl. Neurobiol. 2010, 36:133-156.
56. 2B/- mouse model of spinal muscular atrophy. Neurobiol. Dis. 2013, 49:57-67.
57. Musarella M., Alcaraz G., Caillol G., Boudier J.-L., Couraud F., Autillo-Touati A. Expression of Nav1.6 sodium channels by Schwann cells at neuromuscular junctions: role in the motor endplate disease phenotype. Glia 2006, 53:13-23.
58. Mutsaers C.A., Wishart T.M., Lamont D.J., Riessland M., Schreml J., Comley L.H., Murray L.M., Parson S.H., Lochmuller H., Wirth B., Talbot K., Gillingwater T.H. Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum. Mol. Genet. 2011.
59. Park G.-H., Maeno-Hikichi Y., Awano T., Landmesser L.T., Monani U.R. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J. Neurosci. 2010, 30:12005-12019.
60. Quintanilla R.A., Johnson G.V.W. Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Res. Bull. 2009, 80:242-247.
61. Reynolds M.L., Woolf C.J. Terminal Schwann cells elaborate extensive processes following denervation of the motor endplate. J. Neurocytol. 1992, 21:50-66.
62. Rinaldi C., Grunseich C., Sevrioukova Irina F., Schindler A., Horkayne-Szakaly I., Lamperti C., Landouré G., Kennerson Marina L., Burnett Barrington G., Bönnemann C., Biesecker Leslie G., Ghezzi D., Zeviani M., Fischbeck Kenneth H. Cowchock Syndrome Is Associated with a Mutation in Apoptosis-Inducing Factor. Am. J. Hum. Genet 2012, 91:1095-1102.
63. Rintoul G.L., Reynolds I.J. Mitochondrial trafficking and morphology in neuronal injury. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2010, 1802:143-150.
64. Ripolone M., Ronchi D., Violano R., Vallejo D., Fagiolari G., Barca E., Lucchini V., Colombo I., Villa L., Berardinelli A., Balottin U., Morandi L., Mora M., Bordoni A., Fortunato F., Corti S., Parisi D., Toscano A., Sciacco M., DiMauro S., Comi G.P., Moggio M. Impaired muscle mitochondrial biogenesis and myogenesis in spinal muscular atrophy. JAMA Neurol. 2015, 72:666-675.
65. Rodrigues N., Owen N., Talbot K., Ignatius J., Dubowitz V., Davies K. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum. Mol. Genet. 1995, 4:631-634.
66. Rudnik-Schöneborn S., Goebel H., Schlote W., Molaian S., Omran H., Ketelsen U., Korinthenberg R., Wenzel D., Lauffer H., Kreiss-Nachtsheim M. Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy. Neurology 2003, 60:983-987.
67. Ruiz R., Tabares L. Neurotransmitter release in motor nerve terminals of a mouse model of mild spinal muscular atrophy. J. Anat. 2014, 224:74-84.
68. 2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. J. Neurosci. 2010, 30:849-857.
69. Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W. The DNA sequence and comparative analysis of human chromosome 5. Nature 2004, 431:268-274.
70. Schütz B. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2005, 20:131-140.
71. Son Y.-J., Trachtenberg J.T., Thompson W.J. Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions. Trends Neurosci. 1996, 19:280-285.
72. Su B., Wang X., Zheng L., Perry G., Smith M.A., Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2010, 1802:135-142.
73. Thomson S.R., Nahon J.E., Mutsaers C.A., Thomson D., Hamilton G., Parson S.H., Gillingwater T.H. Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy. PLoS One 2012, 7:e52605.
74. Torres-Benito L., Neher M.F., Cano R., Ruiz R., Tabares L. SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals. PLoS One 2011, 6:e26164.
75. Trudeau M.M., Dalton J.C., Day J.W., Ranum L.P., Meisler M.H. Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation. J. Med. Genet. 2006, 43:527-530.
76. Voigt T., Meyer K., Baum O., Schümperli D. Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing. Neuromuscul. Disord. 2010, 20:744-752.
77. Voigt T., Neve A., Schümperli D. The craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy. Neuropathol. Appl. Neurobiol. 2014, 40:416-434.
78. Wishart T.M., Mutsaers C.A., Riessland M., Reimer M.M., Hunter G., Hannam M.L., Eaton S.L., Fuller H.R., Roche S.L., Somers E., Morse R., Young P.J., Lamont D.J., Hammerschmidt M., Joshi A., Hohenstein P., Morris G.E., Parson S.H., Skehel P.A., Becker T., Robinson I.M., Becker C.G., Wirth B., Gillingwater T.H. Dysregulation of ubiquitin homeostasis and beta-catenin signaling promote spinal muscular atrophy. J. Clin. Invest. 2014, 124:1821-1834.